A novel upregulated LncRNA‐AC026150.8 promotes chemo‐resistance and predicts poor prognosis in acute myeloid leukemia
Abstract Background AML is a common hematological malignancy with poor prognosis, the pathogenesis is still unclear. lncRNA takes part in occurrence and development of AML. This research aims to explore new differentially expressed lncRNAs and their effects on AML. Methods Database‐based bioinformat...
Guardado en:
Autores principales: | Henan Zhang, Yue Zhao, Xuan Liu, Yusi Liu, Xiaohui Wang, Yu Fu, Shuang Fu, Jihong Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/689f2ca585c24685ab3641dbe9572cb0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer
por: Shen,Xiaogang, et al.
Publicado: (2017) -
LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis
por: Wei Yang, et al.
Publicado: (2021) -
LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway
por: Hsu,Wenchan, et al.
Publicado: (2019) -
Based on bioinformatics analysis lncrna SNHG5 modulates the function of vascular smooth muscle cells through mir‐205‐5p/SMAD4 in abdominal aortic aneurysm
por: Han Nie, et al.
Publicado: (2021) -
Super-enhancer-driven lncRNA-DAW promotes liver cancer cell proliferation through activation of Wnt/β-catenin pathway
por: Weicheng Liang, et al.
Publicado: (2021)